Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2015

01.06.2015 | Research Paper

Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer

verfasst von: Ying Chen, Honggang Xiang, Yingfan Zhang, Jiejun Wang, Guanzhen Yu

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Microarray studies revealed down-regulation of PCDH9 mRNA level in lymph node metastasis of gastric cancer compared with the primary tumors. The expression of PCDH9 protein and its clinicopathological relevance were assessed on tissue microarrays of 1072 cases of gastric cancer. Its prognostic value was further evaluated on a small cohort of 175 gastric cancers. PCDH9 was down-regulated during the development and progression of gastric cancer. The overall rates of PCDH9 expression in normal, primary tumor, nodal and hepatic metastatic tissues were 100 % (1072/1072), 48.0 % (515/1072), 20.1 % (34/169), and 5.6 % (1/18), respectively. Positive staining of PCDH9 protein was significantly reversely correlated with tumor size, tumor differentiation, tumor invasion, lymph node metastasis, and disease progression. The Cox proportional hazards model revealed that the PCDH9 was an independent prognostic factor for gastric cancer. Therefore, decreased expression of PCDH9 is frequent in human gastric cancer metastasis and PCDH9 expression is an independent prognostic factor, suggesting that PCDH9 could be a promising biomarker of this malignancy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef
4.
Zurück zum Zitat Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, Jia Z, Li Q, Yao JC, Xie K (2009) Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res 15(5):1821–1829PubMedCrossRef Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, Jia Z, Li Q, Yao JC, Xie K (2009) Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res 15(5):1821–1829PubMedCrossRef
5.
Zurück zum Zitat Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX (2007) Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 26(3–4):705–715PubMedCrossRef Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX (2007) Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 26(3–4):705–715PubMedCrossRef
6.
Zurück zum Zitat Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q, Xie K (2008) Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 25(7):695–702PubMedCrossRef Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q, Xie K (2008) Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 25(7):695–702PubMedCrossRef
8.
Zurück zum Zitat Li W, Ye F, Wang D, Sun X, Tong W, Lian G, Jiang J, Suo J, Zhang DY (2013) Protein predictive signatures for lymph node metastasis of gastric cancer. Int J Cancer 132(8):1851–1859PubMedCrossRef Li W, Ye F, Wang D, Sun X, Tong W, Lian G, Jiang J, Suo J, Zhang DY (2013) Protein predictive signatures for lymph node metastasis of gastric cancer. Int J Cancer 132(8):1851–1859PubMedCrossRef
9.
Zurück zum Zitat Huynh KT, Hoon DS (2012) Epigenetics of regional lymph node metastasis in solid tumors. Clin Exp Metastasis 29(7):747–756PubMedCrossRef Huynh KT, Hoon DS (2012) Epigenetics of regional lymph node metastasis in solid tumors. Clin Exp Metastasis 29(7):747–756PubMedCrossRef
10.
Zurück zum Zitat Leong SP, Witte M (2012) Biomarkers of cancer metastasis through the lymphovascular system: future perspectives. Clin Exp Metastasis 29(7):861–864PubMedCrossRef Leong SP, Witte M (2012) Biomarkers of cancer metastasis through the lymphovascular system: future perspectives. Clin Exp Metastasis 29(7):861–864PubMedCrossRef
11.
Zurück zum Zitat Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N, Biondi A, Gasbarrini A, D’Ugo D (2014) cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg 38(8):2058–2064PubMedCrossRef Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N, Biondi A, Gasbarrini A, D’Ugo D (2014) cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. World J Surg 38(8):2058–2064PubMedCrossRef
12.
Zurück zum Zitat Xu Y, Liu Z, Guo K (2012) Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer. Mol Cell Biochem 363(1–2):93–99PubMedCrossRef Xu Y, Liu Z, Guo K (2012) Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer. Mol Cell Biochem 363(1–2):93–99PubMedCrossRef
13.
Zurück zum Zitat Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J (2012) Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. J Surg Oncol 105(1):31–37PubMedCrossRef Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J (2012) Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. J Surg Oncol 105(1):31–37PubMedCrossRef
14.
Zurück zum Zitat Redies C, Vanhalst K, Roy F (2005) delta-Protocadherins: unique structures and functions. Cell Mol Life Sci 62(23):2840–2852PubMedCrossRef Redies C, Vanhalst K, Roy F (2005) delta-Protocadherins: unique structures and functions. Cell Mol Life Sci 62(23):2840–2852PubMedCrossRef
15.
Zurück zum Zitat Yu B, Yang H, Zhang C, Wu Q, Shao Y, Zhang J, Guan M, Wan J, Zhang W (2010) High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. Neoplasma 57(3):247–252PubMedCrossRef Yu B, Yang H, Zhang C, Wu Q, Shao Y, Zhang J, Guan M, Wan J, Zhang W (2010) High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. Neoplasma 57(3):247–252PubMedCrossRef
16.
Zurück zum Zitat Okazaki N, Takahashi N, Kojima S, Masuho Y, Koga H (2002) Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23(7):1139–1148PubMedCrossRef Okazaki N, Takahashi N, Kojima S, Masuho Y, Koga H (2002) Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23(7):1139–1148PubMedCrossRef
17.
Zurück zum Zitat Jung SP, Kim S, Nam SJ, Kim I, Bae JW (2013) The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis. J Breast Cancer 16(1):16–22PubMedCentralPubMedCrossRef Jung SP, Kim S, Nam SJ, Kim I, Bae JW (2013) The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis. J Breast Cancer 16(1):16–22PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Yuecheng Y, Hongmei L, Xiaoyan X (2006) Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis 23(1):65–74PubMedCrossRef Yuecheng Y, Hongmei L, Xiaoyan X (2006) Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis 23(1):65–74PubMedCrossRef
19.
Zurück zum Zitat Yu GZ, Chen Y, Long YQ, Dong D, Mu XL, Wang JJ (2008) New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma. Oncol Rep 19(5):1191–1204PubMed Yu GZ, Chen Y, Long YQ, Dong D, Mu XL, Wang JJ (2008) New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma. Oncol Rep 19(5):1191–1204PubMed
20.
Zurück zum Zitat Gao Y, Chen Y, Xu D, Wang J, Yu G (2014) Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer 14:520PubMedCentralPubMedCrossRef Gao Y, Chen Y, Xu D, Wang J, Yu G (2014) Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer 14:520PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK et al (2007) Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma. Clin Cancer Res 13(24):7363–7369PubMedCrossRef Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK et al (2007) Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma. Clin Cancer Res 13(24):7363–7369PubMedCrossRef
22.
Zurück zum Zitat Yu JS, Koujak S, Nagase S, Li CM, Su T, Wang X, Keniry M, Memeo L, Rojtman A, Mansukhani M et al (2008) PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27(34):4657–4665PubMedCentralPubMedCrossRef Yu JS, Koujak S, Nagase S, Li CM, Su T, Wang X, Keniry M, Memeo L, Rojtman A, Mansukhani M et al (2008) PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27(34):4657–4665PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Imoto I, Izumi H, Yokoi S, Hosoda H, Shibata T, Hosoda F, Ohki M, Hirohashi S, Inazawa J (2006) Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 66(9):4617–4626PubMedCrossRef Imoto I, Izumi H, Yokoi S, Hosoda H, Shibata T, Hosoda F, Ohki M, Hirohashi S, Inazawa J (2006) Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 66(9):4617–4626PubMedCrossRef
24.
Zurück zum Zitat Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM et al (2009) Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 136(2):640–651PubMedCrossRef Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM et al (2009) Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 136(2):640–651PubMedCrossRef
25.
Zurück zum Zitat Kim SY, Chung HS, Sun W, Kim H (2007) Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience 147(4):996–1021PubMedCrossRef Kim SY, Chung HS, Sun W, Kim H (2007) Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience 147(4):996–1021PubMedCrossRef
26.
Zurück zum Zitat Strehl S, Glatt K, Liu QM, Glatt H, Lalande M (1998) Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics 53(1):81–89PubMedCrossRef Strehl S, Glatt K, Liu QM, Glatt H, Lalande M (1998) Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics 53(1):81–89PubMedCrossRef
27.
Zurück zum Zitat Wang C, Yu G, Liu J, Wang J, Zhang Y, Zhang X, Zhou Z, Huang Z (2012) Downregulation of PCDH9 predicts prognosis for patients with glioma. J Clin Neurosci 19(4):541–545PubMedCrossRef Wang C, Yu G, Liu J, Wang J, Zhang Y, Zhang X, Zhou Z, Huang Z (2012) Downregulation of PCDH9 predicts prognosis for patients with glioma. J Clin Neurosci 19(4):541–545PubMedCrossRef
28.
Zurück zum Zitat Yu G, Gao Y, Ni C, Chen Y, Pan J, Wang X, Ding Z, Wang J (2011) Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer. J Cancer Res Clin Oncol 137(1):73–80PubMedCrossRef Yu G, Gao Y, Ni C, Chen Y, Pan J, Wang X, Ding Z, Wang J (2011) Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer. J Cancer Res Clin Oncol 137(1):73–80PubMedCrossRef
29.
Zurück zum Zitat Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL et al (2014) Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis. Int J Cancer 135(11):2593–2603PubMedCrossRef Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL et al (2014) Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis. Int J Cancer 135(11):2593–2603PubMedCrossRef
30.
Zurück zum Zitat Hu X (2014) Risk factors and prognosis of liver metastasis from gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 17(2):108–111PubMed Hu X (2014) Risk factors and prognosis of liver metastasis from gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 17(2):108–111PubMed
31.
Zurück zum Zitat Wang Y, Liu YF, Cheng Y, Yi DH, Li P, Song WQ, Fu DZ, Wang X (2010) Prognosis of colorectal cancer with liver metastasis: value of a prognostic index. Braz J Med Biol Res 43(11):1116–1122PubMedCrossRef Wang Y, Liu YF, Cheng Y, Yi DH, Li P, Song WQ, Fu DZ, Wang X (2010) Prognosis of colorectal cancer with liver metastasis: value of a prognostic index. Braz J Med Biol Res 43(11):1116–1122PubMedCrossRef
32.
Zurück zum Zitat Ozturk E, Kilicturgay S, Yilmazlar T, Zorluoglu A, Ozen Y (2010) Factors affecting the prognosis of patients with colorectal liver metastasis. Acta Chir Belg 110(2):189–194PubMed Ozturk E, Kilicturgay S, Yilmazlar T, Zorluoglu A, Ozen Y (2010) Factors affecting the prognosis of patients with colorectal liver metastasis. Acta Chir Belg 110(2):189–194PubMed
33.
Zurück zum Zitat Solomon DA, Kim JS, Ressom HW, Sibenaller Z, Ryken T, Jean W, Bigner D, Yan H, Waldman T (2009) Sample type bias in the analysis of cancer genomes. Cancer Res 69(14):5630–5633PubMedCentralPubMedCrossRef Solomon DA, Kim JS, Ressom HW, Sibenaller Z, Ryken T, Jean W, Bigner D, Yan H, Waldman T (2009) Sample type bias in the analysis of cancer genomes. Cancer Res 69(14):5630–5633PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Bouillot S, Tillet E, Carmona G, Prandini MH, Gauchez AS, Hoffmann P, Alfaidy N, Cand F, Huber P (2011) Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia. J Biol Chem 286(17):15195–15204PubMedCentralPubMedCrossRef Bouillot S, Tillet E, Carmona G, Prandini MH, Gauchez AS, Hoffmann P, Alfaidy N, Cand F, Huber P (2011) Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia. J Biol Chem 286(17):15195–15204PubMedCentralPubMedCrossRef
Metadaten
Titel
Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer
verfasst von
Ying Chen
Honggang Xiang
Yingfan Zhang
Jiejun Wang
Guanzhen Yu
Publikationsdatum
01.06.2015
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2015
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-015-9712-7

Weitere Artikel der Ausgabe 5/2015

Clinical & Experimental Metastasis 5/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.